On 2018-05-15, Anthera Pharmaceuticals, Inc. (ANTH) announced earnings per share of $-0.42 for the fiscal quarter ending 2018-03-31, beating the average analyst estimate of $-0.60.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2018-05-15 | 2018-03-31 | $-0.60 | $-0.42 |
| 2018-03-05 | 2017-12-31 | $-0.71 | $-0.73 |
| 2017-11-06 | 2017-09-30 | $-0.90 | $-0.58 |
| 2017-08-09 | 2017-06-30 | $-1.08 | $-0.86 |
| 2017-05-10 | 2017-03-31 | $-1.39 | $-2.03 |
| 2017-02-27 | 2016-12-31 | $-3.28 | $-2.88 |
| 2016-11-04 | 2016-09-30 | $-2.80 | $-4.88 |
| 2016-08-09 | 2016-06-30 | $-2.48 | $-2.80 |
| 2016-05-09 | 2016-03-31 | $-2.32 | $-2.32 |
| 2016-03-10 | 2015-12-31 | $-2.24 | $-1.44 |
| 2015-11-06 | 2015-09-30 | $-2.08 | $-2.32 |
| 2015-08-10 | 2015-06-30 | $-2.24 | $-2.00 |
| 2015-05-11 | 2015-03-31 | $-2.48 | $-2.24 |
| 2015-03-16 | 2014-12-31 | $-2.64 | $-2.56 |